BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 30852420)

  • 1. Prognostic gene expression signature for high-grade serous ovarian cancer.
    Millstein J; Budden T; Goode EL; Anglesio MS; Talhouk A; Intermaggio MP; Leong HS; Chen S; Elatre W; Gilks B; Nazeran T; Volchek M; Bentley RC; Wang C; Chiu DS; Kommoss S; Leung SCY; Senz J; Lum A; Chow V; Sudderuddin H; Mackenzie R; George J; ; Fereday S; Hendley J; Traficante N; Steed H; Koziak JM; Köbel M; McNeish IA; Goranova T; Ennis D; Macintyre G; Silva De Silva D; Ramón Y Cajal T; García-Donas J; Hernando Polo S; Rodriguez GC; Cushing-Haugen KL; Harris HR; Greene CS; Zelaya RA; Behrens S; Fortner RT; Sinn P; Herpel E; Lester J; Lubiński J; Oszurek O; Tołoczko A; Cybulski C; Menkiszak J; Pearce CL; Pike MC; Tseng C; Alsop J; Rhenius V; Song H; Jimenez-Linan M; Piskorz AM; Gentry-Maharaj A; Karpinskyj C; Widschwendter M; Singh N; Kennedy CJ; Sharma R; Harnett PR; Gao B; Johnatty SE; Sayer R; Boros J; Winham SJ; Keeney GL; Kaufmann SH; Larson MC; Luk H; Hernandez BY; Thompson PJ; Wilkens LR; Carney ME; Trabert B; Lissowska J; Brinton L; Sherman ME; Bodelon C; Hinsley S; Lewsley LA; Glasspool R; Banerjee SN; Stronach EA; Haluska P; Ray-Coquard I; Mahner S; Winterhoff B; Slamon D; Levine DA; Kelemen LE; Benitez J; Chang-Claude J; Gronwald J; Wu AH; Menon U; Goodman MT; Schildkraut JM; Wentzensen N; Brown R; Berchuck A; Chenevix-Trench G; deFazio A; Gayther SA; García MJ; Henderson MJ; Rossing MA; Beeghly-Fadiel A; Fasching PA; Orsulic S; Karlan BY; Konecny GE; Huntsman DG; Bowtell DD; Brenton JD; Doherty JA; Pharoah PDP; Ramus SJ
    Ann Oncol; 2020 Sep; 31(9):1240-1250. PubMed ID: 32473302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Germline Variant at 8q24 Contributes to Familial Clustering of Prostate Cancer in Men of African Ancestry.
    Darst BF; Wan P; Sheng X; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Stevens VL; Berndt SI; Huff CD; Strom SS; Park JY; Zheng W; Ostrander EA; Walsh PC; Srivastava S; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Yeager M; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Kote-Jarai Z; Govindasami K; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach R; Gundell SM; Pooler L; Xia L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Eeles RA; Brureau L; Chanock SJ; Watya S; Stanford JL; Mandal D; Isaacs WB; Cooney K; Blot WJ; Conti DV; Haiman CA
    Eur Urol; 2020 Sep; 78(3):316-320. PubMed ID: 32409115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrin α6 mediates the drug resistance of acute lymphoblastic B-cell leukemia.
    Gang EJ; Kim HN; Hsieh YT; Ruan Y; Ogana HA; Lee S; Pham J; Geng H; Park E; Klemm L; Willman CL; Carroll WL; Mittelman SD; Orgel E; Oberley MJ; Parekh C; Abdel-Azim H; Bhojwani D; Wayne AS; De Arcangelis A; Georges-Labouesse E; Wayner E; Bonig H; Minasyan A; Ten Hoeve J; Graeber TG; Müschen M; Heisterkamp N; Kim YM
    Blood; 2020 Jul; 136(2):210-223. PubMed ID: 32219444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer transcriptomic profiling from rapidly enriched circulating tumor cells.
    Morrison GJ; Cunha AT; Jojo N; Xu Y; Xu Y; Kwok E; Robinson P; Dorff T; Quinn D; Carpten J; Manojlovic Z; Goldkorn A
    Int J Cancer; 2020 May; 146(10):2845-2854. PubMed ID: 32037533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HiLDA: a statistical approach to investigate differences in mutational signatures.
    Yang Z; Pandey P; Shibata D; Conti DV; Marjoram P; Siegmund KD
    PeerJ; 2019; 7():e7557. PubMed ID: 31523512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A latent unknown clustering integrating multi-omics data (LUCID) with phenotypic traits.
    Peng C; Wang J; Asante I; Louie S; Jin R; Chatzi L; Casey G; Thomas DC; Conti DV
    Bioinformatics; 2020 Feb; 36(3):842-850. PubMed ID: 31504184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partition: a surjective mapping approach for dimensionality reduction.
    Millstein J; Battaglin F; Barrett M; Cao S; Zhang W; Stintzing S; Heinemann V; Lenz HJ
    Bioinformatics; 2020 Feb; 36(3):676-681. PubMed ID: 31504178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide association study of prostate cancer in Latinos.
    Du Z; Hopp H; Ingles SA; Huff C; Sheng X; Weaver B; Stern M; Hoffmann TJ; John EM; Van Den Eeden SK; Strom S; Leach RJ; Thompson IM; Witte JS; Conti DV; Haiman CA
    Int J Cancer; 2020 Apr; 146(7):1819-1826. PubMed ID: 31226226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta-analysis using TRIBE, MAVERICC and FIRE3.
    Tokunaga R; Cao S; Naseem M; Battaglin F; Lo JH; Arai H; Loupakis F; Stintzing S; Puccini A; Berger MD; Soni S; Zhang W; Mancao C; Salhia B; Mumenthaler SM; Weisenberger DJ; Liang G; Cremolini C; Heinemann V; Falcone A; Millstein J; Lenz HJ
    Int J Cancer; 2019 Oct; 145(8):2082-2090. PubMed ID: 30856283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct genomic landscapes of gastroesophageal adenocarcinoma depending on PD-L1 expression identify mutations in RAS-MAPK pathway and TP53 as potential predictors of immunotherapy efficacy.
    Wang JY; Xiu J; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Oberley M; Spetzler D; Shen L; Korn WM; Lenz HJ
    Ann Oncol; 2021 Jul; 32(7):906-916. PubMed ID: 33798656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment.
    Eigeliene N; Saarenheimo J; Wichmann V; Österlund P; Jekunen A
    Case Rep Oncol; 2021; 14(3):1475-1482. PubMed ID: 34899239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring DNA Methylation Profiles Altered in Cryptogenic Hepatocellular Carcinomas by High-Throughput Targeted DNA Methylation Sequencing: A Preliminary Study for Cryptogenic Hepatocellular Carcinoma.
    Wang X; Cheng Y; Yan LL; An R; Wang XY; Wang HY
    Onco Targets Ther; 2020; 13():9901-9916. PubMed ID: 33116575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of magnetic nanoparticles in nucleic acid detection.
    Tang C; He Z; Liu H; Xu Y; Huang H; Yang G; Xiao Z; Li S; Liu H; Deng Y; Chen Z; Chen H; He N
    J Nanobiotechnology; 2020 Apr; 18(1):62. PubMed ID: 32316985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3.
    Puccini A; Loupakis F; Stintzing S; Cao S; Battaglin F; Togunaka R; Naseem M; Berger MD; Soni S; Zhang W; Mancao C; Salhia B; Mumenthaler SM; Weisenberger DJ; Liang G; Cremolini C; Heinemann V; Falcone A; Millstein J; Lenz HJ
    Eur J Cancer; 2019 Apr; 111():138-147. PubMed ID: 30852420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICC.
    Arai H; Cao S; Battaglin F; Wang J; Kawanishi N; Tokunaga R; Loupakis F; Stintzing S; Soni S; Zhang W; Mancao C; Salhia B; Mumenthaler SM; Cremolini C; Heinemann V; Falcone A; Millstein J; Lenz HJ
    Mol Cancer Ther; 2021 Jun; 20(6):1153-1160. PubMed ID: 33785650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trials.
    Wang J; Millstein J; Yang Y; Stintzing S; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Mancao C; Cremolini C; Liu T; Heinemann V; Falcone A; Shen L; Lenz HJ
    EClinicalMedicine; 2023 Mar; 57():101827. PubMed ID: 36816347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer.
    Rawłuszko-Wieczorek AA; Siera A; Horbacka K; Horst N; Krokowicz P; Jagodziński PP
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1379-92. PubMed ID: 25557833
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.